Calcineurin-mediated dephosphorylation stabilizes E2F1 protein by suppressing binding of the FBXW7 ubiquitin ligase

Yuki Sato1, Makoto Habara1, Shunsuke Hanaki1

  • 1Department of Veterinary Biochemistry, Yamaguchi University, Yamaguchi 753-8511, Japan.

Insights

The ubiquitin ligase SCFFBXW7 targets E2F1 for degradation, a process inhibited by calcineurin. This pathway regulates cell proliferation and cancer development, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • E2F1 is a key cell cycle regulator and transcription factor.
  • E2F1 overexpression is linked to cancer progression.
  • Targeting E2F1 degradation may offer novel cancer therapies.

Purpose of the Study:

  • To identify the ubiquitin ligase responsible for E2F1 degradation.
  • To elucidate the regulatory mechanisms controlling E2F1 stability.
  • To explore the therapeutic potential of modulating E2F1 levels in cancer.

Main Methods:

  • Comprehensive analysis to identify SCFFBXW7 as the E2F1 ubiquitin ligase.
  • Investigated the role of E2F1 phosphorylation at serine-403 in FBXW7 binding.
  • Assessed the impact of calcineurin activity on E2F1 stability.
  • Utilized calcium channel blockers, ionomycin, and FK506 in cellular and in vivo models.

Main Results:

  • SCFFBXW7 was identified as the ubiquitin ligase for E2F1.
  • Phosphorylation of E2F1 at serine-403 promotes its degradation via FBXW7.
  • Calcineurin dephosphorylates E2F1 at serine-403, stabilizing the protein.
  • Calcium modulation and calcineurin inhibition affect E2F1 levels and target gene expression.
  • FK506 treatment inhibited tumor growth in mice by downregulating E2F1.

Conclusions:

  • The balance between FBXW7-mediated degradation and calcineurin-mediated stabilization of E2F1 is crucial for cell proliferation and cancer.
  • Dysregulation of this balance contributes to carcinogenesis.
  • Targeting the FBXW7-calcineurin-E2F1 axis presents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...